Artios Announces ATR Inhibitor, ART0380, Development On Track and Progressing Into Phase 1b Evaluation
| Press release
News & Events
Artios attending the AACR in New Orleans 8-12 April 2022
| Conferences
Graeme Smith, CSO and Helen Robinson, VP Biology attending the 5th Digital DDR, ATR, & PARP Summit – 25/26 January 2022
| Conferences
Listen to our CEO and CSO talk at the Northland Synthetic Lethality Conference – Nov 17 2021
| Conferences
Artios Announces $153 Million (£110 Million) Series C Financing Led by Omega Funds and TCG X
| Press release
Exciting press coverage following our Polθ (Pol-theta) press release – Nature Communications
| Media coverage
Our press coverage following our Novartis collaboration
| Media coverage
